Le Lézard
Classified in: Oil industry, Science and technology
Subjects: CCA, FVT

ClearSign Technologies Corporation Announces First Quarter 2022 Conference Call and Virtual Annual Meeting


Hosting Q1 Call at 5pm ET on Thursday, June 2, 2022

Virtual Annual Meeting to be Held on June 6th at 2pm ET (1pm CT)

TULSA, Okla., May 16, 2022 /PRNewswire/ -- ClearSign Technologies Corporation (Nasdaq: CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion and sensing technologies that improve energy, operational efficiency and safety while dramatically reducing emissions, announces that on Thursday, June 2, 2022 the Company will host a conference call at 5:00 PM ET.  The Company will file its quarterly report on form 10-Q with the SEC later today and will issue a summary of its financial and operating results for the quarter ending on March 31, 2022 in a press release on the day of the call. 

Investors interested in participating on the live First Quarter call can dial 1-866-372-4653 within the U.S. or 1-412-902-4217 from abroad. Investors can also access the call online through a listen-only webcast at  https://app.webinar.net/kGyrnlQ0VPX or on the investor relations section of the Company's website at http://ir.clearsign.com/overview.

The webcast will be archived on the Company's investor relations website for at least 90 days and a telephonic playback of the conference call will be available by calling 1-877-344-7529 within the U.S. or 1-412-317-0088 from abroad. The conference ID is 5976170.The telephonic playback will be available for 7 days after the conference call.

Investors are also invited to attend the 2022 annual meeting of shareholders of ClearSign Technologies Corporation (the "Annual Meeting") on June 6, 2022 at 1:00 p.m. Central Daylight Standard Time. In order to protect the health and safety of our shareholders and employees, the Annual Meeting will be completely virtual conducted live via the Internet. You will be able to attend the Annual Meeting online. To participate in the Annual Meeting, visit www.virtualshareholdermeeting.com/CLIR2022 and enter the 16-digit control number included on your Notice of Internet Availability, proxy card, or voting instruction form. You may begin to log into the meeting platform beginning at 12:45 p.m. that day.  Shareholders will also have the opportunity to submit questions during the Annual Meeting through the same link.  A technical support telephone number will be posted on the log-in page of www.virtualshareholdermeeting.com/CLIR2022 you can call if you encounter any difficulties accessing the virtual meeting during the meeting.

About ClearSign Technologies Corporation

ClearSign Technologies Corporation designs and develops products and technologies for the purpose of improving key performance characteristics of industrial and commercial systems, including operational performance, energy efficiency, emission reduction, safety and overall cost-effectiveness. Our patented technologies, embedded in established OEM products as ClearSign Coretm, and ClearSign Eyetm and other sensing configurations, enhance the performance of combustion systems and fuel safety systems in a broad range of markets, including the energy (upstream oil production and down-stream refining), commercial/industrial boiler, chemical, petrochemical, transport and power industries. For more information, please visit www.clearsign.com.

SOURCE ClearSign Technologies Corporation


These press releases may also interest you

at 22:21
A music video for the theme song celebrating the 25th anniversary of Hong Kong Special Administrative Region (SAR)'s return to the motherland was released by China Media Group on Friday.   The theme song "We Will Be...

at 21:49
Beijing Dabeinong Science and Technology Group Co., Ltd. ("DBN"), an agricultural high-tech enterprise, will host 12th DBN Science and Technology Award ceremony ("the Ceremony") in Beijing on June 28, which is going to simultaneously livestream with...

at 21:33
When Claudia Gerini was growing up in Italy, she probably didn't think she would be helping lead a mental healthcare revolution on the other side of the Atlantic. With her new movie Tapirulàn or The Treadmill (trailer) debuting at the Bell Lightbox...

at 21:05
Italfarmaco Group announced today positive topline data from its completed Phase 3 EPIDYS trial with Givinostat, the company's proprietary histone deacetylase (HDAC) inhibitor, in boys with Duchenne Muscular Dystrophy (DMD). The primary objective of...

at 20:00
On June 15, 2022, Dragon Boat announced that its IND application of the innovative anti-CLDN 18.2/CD47 bi-specific antibody (bsAb) injection (R&D code: BC007) was officially accepted by National Medical Products Administration (NMPA) under the...

at 12:30
New data presented in two separate oral presentations at the European Association for the Study of the Liver's International Liver Congress 2022 (EASL ILC 2022)Following 90 days of dosing, ATI-2173, in combination with tenofovir disoproxil fumarate...



News published on 16 may 2022 at 08:30 and distributed by: